Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic.
Stem Cell Reports
; 16(11): 2567-2576, 2021 11 09.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1525954
ABSTRACT
The significant morbidity and mortality of coronavirus disease 19 (COVID-19) prompted a global race to develop new therapies. These include interventions using cell- or cell-derived products, several of which are being tested in well-designed, properly controlled clinical trials. Yet, the search for cell-based COVID-19 treatments has also been fraught with hyperbolic claims; flouting of crucial regulatory, scientific, and ethical norms; and distorted communication of research findings. In this paper, we critically examine ethical issues and public communication challenges related to the development of cell-based therapeutics for COVID-19. Drawing on the lessons learned from this ongoing process, we argue against the rushed development of cell-based interventions. We conclude by outlining ways to improve the ethical conduct of cell-based clinical investigations and public communication of therapeutic claims.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Terapéutica
/
Comunicación
/
Trasplante de Células Madre
/
Pandemias
/
SARS-CoV-2
/
COVID-19
Tipo de estudio:
Estudio experimental
/
Estudio pronóstico
Límite:
Humanos
Idioma:
Inglés
Revista:
Stem Cell Reports
Año:
2021
Tipo del documento:
Artículo
País de afiliación:
J.stemcr.2021.09.005
Similares
MEDLINE
...
LILACS
LIS